NCT03951727View on ClinicalTrials.gov

Stella Supera Siberia

NAUnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions

AtherosclerosisPeripheral Arterial DiseaseSuperficial Femoral Artery Occlusion

Interventions

DEVICE

Endovascular treatment for PAD

Long femoropopliteal stenting with SuperA devices

Trial Locations (1)

630005

RECRUITING

Alexander A Gostev, Novosibirsk

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK